Literature DB >> 34112003

Role of platelets in the pathogenesis of delayed injury after subarachnoid hemorrhage.

Ari Dienel1, Peeyush Kumar T1, Spiros L Blackburn1, Devin W McBride1.   

Abstract

Aneurysmal subarachnoid hemorrhage (aSAH) patients develop delayed cerebral ischemia and delayed deficits (DCI) within 2 weeks of aneurysm rupture at a rate of approximately 30%. DCI is a major contributor to morbidity and mortality after SAH. The cause of DCI is multi-factorial with contributions from microthrombi, blood vessel constriction, inflammation, and cortical spreading depolarizations. Platelets play central roles in hemostasis, inflammation, and vascular function. Within this review, we examine the potential roles of platelets in microthrombi formation, large artery vasospasm, microvessel constriction, inflammation, and cortical spreading depolarization. Evidence from experimental and clinical studies is provided to support the role(s) of platelets in each pathophysiology which contributes to DCI. The review concludes with a suggestion for future therapeutic targets to prevent DCI after aSAH.

Entities:  

Keywords:  Subarachnoid hemorrhage; aneurysm; delayed cerebral ischemia; delayed deficits; platelets

Mesh:

Substances:

Year:  2021        PMID: 34112003      PMCID: PMC8756481          DOI: 10.1177/0271678X211020865

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.960


  110 in total

1.  Bioassay of platelet-activating factor by release of [3H]serotonin.

Authors:  P M Henson
Journal:  Methods Enzymol       Date:  1990       Impact factor: 1.600

2.  Thromboembolism and delayed cerebral ischemia after subarachnoid hemorrhage: an autopsy study.

Authors:  Sherman C Stein; Kevin D Browne; Xiao-Han Chen; Douglas H Smith; David I Graham
Journal:  Neurosurgery       Date:  2006-10       Impact factor: 4.654

3.  Luminal platelet aggregates in functional deficits in parenchymal vessels after subarachnoid hemorrhage.

Authors:  Victor Friedrich; Rowena Flores; Artur Muller; Fatima A Sehba
Journal:  Brain Res       Date:  2010-07-21       Impact factor: 3.252

Review 4.  The role of spreading depression, spreading depolarization and spreading ischemia in neurological disease.

Authors:  Jens P Dreier
Journal:  Nat Med       Date:  2011-04-07       Impact factor: 53.440

5.  Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multidisciplinary research group.

Authors:  Mervyn D I Vergouwen; Marinus Vermeulen; Jan van Gijn; Gabriel J E Rinkel; Eelco F Wijdicks; J Paul Muizelaar; A David Mendelow; Seppo Juvela; Howard Yonas; Karel G Terbrugge; R Loch Macdonald; Michael N Diringer; Joseph P Broderick; Jens P Dreier; Yvo B W E M Roos
Journal:  Stroke       Date:  2010-08-26       Impact factor: 7.914

6.  Postoperative intracranial thrombolysis and angioplasty.

Authors:  O Levrier; J M Stordeur; N Bruder; L Manera; P Bouillot; C H Raybaud
Journal:  Interv Neuroradiol       Date:  2002-01-10       Impact factor: 1.610

Review 7.  Delayed neurological deterioration after subarachnoid haemorrhage.

Authors:  R Loch Macdonald
Journal:  Nat Rev Neurol       Date:  2013-12-10       Impact factor: 42.937

8.  Rapidly increased vasopressin promotes acute platelet aggregation and early brain injury after experimental subarachnoid hemorrhage in a rat model.

Authors:  Zun-Wei Liu; Hua Gu; Bin-Fei Zhang; Ya-Hui Zhao; Jun-Jie Zhao; Yong-Lin Zhao; Xu-Dong Ma; Jin-Ning Song
Journal:  Brain Res       Date:  2016-03-02       Impact factor: 3.252

9.  Tirofiban Protocol Protects Against Delayed Cerebral Ischemia: A Case-Series Study.

Authors:  Mario Zanaty; Carlos Osorno-Cruz; Stefano Byer; Jorge A Roa; Kaustubh Limaye; Daizo Ishii; Daichi Nakagawa; James Torner; Lu Yongjun; Santiago Ortega-Gutiérrez; Edgar A Samaniego; Lauren Allan; David Hasan
Journal:  Neurosurgery       Date:  2020-10-15       Impact factor: 4.654

10.  Safety of tirofiban and dual antiplatelet therapy in treating intracranial aneurysms.

Authors:  Edgar A Samaniego; Emilee Gibson; Daichi Nakagawa; Santiago Ortega-Gutierrez; Mario Zanaty; Jorge A Roa; Pascal Jabbour; David M Hasan
Journal:  Stroke Vasc Neurol       Date:  2019-02-03
View more
  1 in total

Review 1.  Targeting Hemoglobin to Reduce Delayed Cerebral Ischemia After Subarachnoid Hemorrhage.

Authors:  Hussein A Zeineddine; Pedram Honarpisheh; Devin McBride; Peeyush Kumar Thankamani Pandit; Ari Dienel; Sung-Ha Hong; James Grotta; Spiros Blackburn
Journal:  Transl Stroke Res       Date:  2022-02-14       Impact factor: 6.800

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.